{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:44:54Z","timestamp":1767134694051,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":49,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd000030","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:20:09Z","timestamp":1069366809000},"source":"Crossref","is-referenced-by-count":0,"title":["Antipsychotic medication for those with both schizophrenia and learning disability"],"prefix":"10.1002","author":[{"given":"L","family":"Duggan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Brylewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,7,23]]},"reference":[{"key":"10.1002\/14651858.CD000030-BIB1|cit1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bjp.104.434.201","article-title":"Combined chlorpromazine and reserpine in the treatment of chronic psychotics","volume":"104","author":"Foote","year":"1958","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD000030-BIB2|cit2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/070674377201700209","article-title":"Propericiazine in psychiatric emergencies. A controlled comparative study","volume":"17","author":"Ananth","year":"1972","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD000030-BIB3|cit3","first-page":"967","volume":"20","author":"Angst","year":"1970","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/14651858.CD000030-BIB4|cit4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000118075","article-title":"Pharmacotherapy of agitational states in psychiatric gerontology: double-blind study: febarbamat-pipamperon","volume":"11","author":"Brenner","year":"1984","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD000030-BIB5|cit5","first-page":"440","article-title":"The use of clozapine in a mentally retarded and aggressive population","volume":"55","author":"Cohen","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB6|cit6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000118170","article-title":"The effect of milenperone on the agressive behavior of oligophrenic patients: a double-blind placebo-controlled study","volume":"13","author":"Cuyper","year":"1985","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD000030-BIB7|cit7","first-page":"71","volume":"34","author":"Guzman","year":"1971","journal-title":"Archivos de Neurobiologia"},{"key":"10.1002\/14651858.CD000030-BIB8|cit8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/009127006600600608","article-title":"Lack of addiction from high doses of tybamate","volume":"6","author":"Feldman","year":"1966","journal-title":"Journal of New Drugs"},{"key":"10.1002\/14651858.CD000030-BIB9|cit9","first-page":"302","volume":"22","author":"Fracassi","year":"1976","journal-title":"Acta Psiquiatrica y Psicologica de America Latina"},{"key":"10.1002\/14651858.CD000030-BIB10|cit10","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00005053-198911000-00005","article-title":"Multiple versus single antipsychotic drug treatment in chronic psychosis","volume":"177","author":"Godleski","year":"1989","journal-title":"Journal of Nervous Mental Disease"},{"key":"10.1002\/14651858.CD000030-BIB11|cit11","first-page":"5","article-title":"Cis(Z)-clopenthixol - the neuroleptically active isomer of clopenthixol: a presentation of five double-blind clinical investigations and other studies with cis(Z)-clopenthixol (Cisordinol, Clopixol)","volume":"294","author":"Gravem","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000030-BIB12|cit12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0447.1981.tb06210.x","article-title":"A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients","volume":"294","author":"Heikkila","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD000030-BIB13|cit13","first-page":"131","article-title":"Mesoridazine (TPS 23 Sandoz) in acute psychotic states","volume":"112","author":"Jost","year":"1973","journal-title":"Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie"},{"key":"10.1002\/14651858.CD000030-BIB14|cit14","first-page":"39","article-title":"Neuroleptic treatment of oligophrenic patients. A double-blind multicentre trial of cis(z)-clopenthixol and haloperidol","volume":"294","author":"Karsten","year":"1981","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1002\/14651858.CD000030-BIB15|cit15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00408335","volume":"9","author":"Kuhn","year":"1966","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD000030-BIB16|cit16","first-page":"177","volume":"13","author":"Kumpel","year":"1971","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000030-BIB17|cit17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1192\/bjp.112.482.95","article-title":"A controlled trial of prothipendyl (tolnate) in mentally subnormal patients","volume":"112","author":"McKenzie","year":"1966","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB18|cit18","first-page":"316","article-title":"Diagnosis and pharmacotherapy of schizophrenia in the retarded","volume":"21","author":"Menolascino","year":"1985","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD000030-BIB19|cit19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08039486709094598","volume":"21","author":"Nielsen","year":"1967","journal-title":"Nordisk Psykiatrisk Tidsskrift"},{"key":"10.1002\/14651858.CD000030-BIB20|cit20","first-page":"168","article-title":"Clinical experience with carpipramine (Defekton)","volume":"16","author":"Pislova","year":"1974","journal-title":"Activitas Nervosa Superior"},{"key":"10.1002\/14651858.CD000030-BIB21|cit21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0010-440X(94)90166-X","article-title":"The use of clozapine in borderline intellectual functioning and mentally retarded schizophrenic patients","volume":"35","author":"Sajatovic","year":"1994","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/106002809202601114","article-title":"Nonneuroleptic treatment of disruptive behavior in organic mental syndromes","volume":"26","author":"Smith","year":"1992","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD000030-BIB23|cit23","first-page":"483","article-title":"The effect of a protriptyline-perphenazine combination in chronic psychiatric patients","volume":"8","author":"St-Jean","year":"1966","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD000030-BIB24|cit24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0140-6736(93)92660-L","article-title":"Eltoprazine for aggression in schizophrenia and mental retardation","volume":"341","author":"Tiihonen","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD000030-BIB25|cit25","first-page":"737","article-title":"Loxapine succinate in the treatment of uncontrollable destructive behavior","volume":"13","author":"Varga","year":"1971","journal-title":"Current Therapeutic Research Clinical Experimental"},{"key":"10.1002\/14651858.CD000030-BIB26|cit26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/030006058000800104","article-title":"Loxapine versus thioridazine in the treatment of organic psychosis","volume":"8","author":"Versiani","year":"1980","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD000030-BIB27|cit27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1600-0447.1971.tb02219.x","article-title":"Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients","volume":"47","author":"Zwanikken","year":"1971","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000030-BIB28|cit28","first-page":"83","article-title":"Penfluridol ( R16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial","volume":"76","author":"Zwanikken","year":"1973","journal-title":"Psychiatria, Neurologia, Neurochirugia"},{"key":"10.1002\/14651858.CD000030-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD000030-BIB30|cit30","article-title":"Drugs and learning in mentally retarded persons","volume-title":"Advances in human psychopharmacology","author":"Aman","year":"1984"},{"key":"10.1002\/14651858.CD000030-BIB31|cit31","volume-title":"British National Formulary","year":"2000"},{"key":"10.1002\/14651858.CD000030-BIB32|cit32","first-page":"385","article-title":"Psychotropic drugs and mental retardation: I. Disabilities and the prescription of drugs for behaviour and for epilepsy in three residential settings","volume":"34","author":"Clarke","year":"1990","journal-title":"Journal of Mental Deficiency Research"},{"key":"10.1002\/14651858.CD000030-BIB33|cit33","article-title":"Cochrane Collaboration Handbook [updated 1 July 1999]","author":"Clarke","journal-title":"The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration"},{"key":"10.1002\/14651858.CD000030-BIB34|cit34","first-page":"11","article-title":"Psychiatric morbidity and mental retardation","volume-title":"Psychiatric illness and mental handicap","author":"Corbett","year":"1979"},{"key":"10.1002\/14651858.CD000030-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.139.10.1297","article-title":"Psychiatric disorders in the mentally retarded: types, problems and challenges","volume":"139","author":"Eaton","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB36|cit36","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1192\/bjp.149.1.68","article-title":"Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: epidemiological aspects","volume":"49","author":"Gillberg","year":"1986","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB37|cit37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2788.1994.tb00347.x","article-title":"A controlled community study of movement disorder in people with learning difficulties on antipsychotic medication","volume":"37","author":"Gingell","year":"1994","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1002\/14651858.CD000030-BIB38|cit38","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1192\/bjp.130.6.525","article-title":"Psychosis in mental handicap","volume":"130","author":"Heaton-Ward","year":"1977","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB39|cit39","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/schbul\/12.1.52","article-title":"Epidemiology of schizophrenia: a European perspective","volume":"12","author":"Jablensky","year":"1986","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD000030-BIB40|cit40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1600-0447.1985.tb02655.x","article-title":"The prevalence of psychiatric morbidity in mentally retarded adults","volume":"72","author":"Lund","year":"1985","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD000030-BIB41|cit41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB42|cit42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1037\/0022-006X.62.1.6","article-title":"Theories of dual diagnosis in mental retardation","volume":"62","author":"Matson","year":"1994","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1002\/14651858.CD000030-BIB43|cit43","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4684-4742-2_1","article-title":"The nature and incidence of mental illness in mentally retarded individuals","volume-title":"Handbook of mental illness in the mentally retarded","author":"Parson","year":"1984"},{"key":"10.1002\/14651858.CD000030-BIB44|cit44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1192\/bjp.158.1.97","article-title":"The motor disorders of mental handicap. An overlap with the motor disorders of severe psychiatric illness","volume":"158","author":"Rogers","year":"1991","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB45|cit45","first-page":"35","article-title":"A neuropsychiatric study in childhood","volume-title":"Clinics in developmental medicine","author":"Rutter","year":"1970"},{"key":"10.1002\/14651858.CD000030-BIB46|cit46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/00048679209072033","article-title":"Drug induced movement disorders in institutionalised adults with mental retardation. Clinical characteristics and risk factors","volume":"26","author":"Sachdev","year":"1992","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB47|cit47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0920-9964(95)00013-C","article-title":"Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground","volume":"16","author":"Weinberger","year":"1995","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD000030-BIB48|cit48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1192\/bjp.157.1.101","article-title":"Reduction in antipsychotic drug dosage in mentally handicapped patients; a hospital study","volume":"157","author":"Wressell","year":"1990","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD000030-BIB49|cit49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/jnnp.51.6.863","article-title":"Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy; relationship to developmental\/ intellectual deficit and presence or absence of long term exposure to neuroleptics","volume":"51","author":"Youseff","year":"1988","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd000030.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2004,10,18]],"date-time":"2004-10-18T00:00:00Z","timestamp":1098057600000}}],"container-title":["The Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000030\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:05:26Z","timestamp":1704960326000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7,23]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd000030","relation":{},"subject":[],"published":{"date-parts":[[2001,7,23]]}}}